Target Name: ZNF233
NCBI ID: G353355
Review Report on ZNF233 Target / Biomarker Content of Review Report on ZNF233 Target / Biomarker
ZNF233
Other Name(s): ZNF233 variant 1 | Zinc finger protein 233 | Zinc finger protein 233, transcript variant 1 | Zinc finger protein 233 (isoform 1) | zinc finger protein 233 | ZN233_HUMAN

ZNF233: A Unique Gene Encoding ZNF2 Protein with Distinct Functional Characteristics

ZNF233 (ZNF233 variant 1) is a gene that encodes for a protein known as ZNF2. ZNF2 is a transcription factor that plays a crucial role in regulating gene expression and is involved in the development, growth, and maintenance of tissues. Mutations in the ZNF2 gene have been linked to a range of developmental and physiological processes, including growth delays, autoimmune diseases, and cancer.

The ZNF2 gene has four splice variants, each with a different length of the coding region. ZNF233 is one of these variants, and it is missense, which means that the substitution of a specific amino acid for another has resulted in a change in the function of the protein. The ZNF233 variant has been shown to have unique functional characteristics compared to the other splice variants.

One of the key differences between the ZNF233 variant and the other splice variants is its stability. Unlike the other variants, ZNF233 is highly stable and has been shown to have a long half-life of several days. This stability is important for the ZNF2 protein because it allows the protein to interact with other proteins and factors for a longer period of time, which is crucial for its function.

Another difference between the ZNF233 variant and the other splice variants is its stability in the body. Unlike the other variants, ZNF233 is not expressed in many tissues and organs, which is important for its function because it is involved in the development and maintenance of tissues. The lack of expression in many tissues means that the ZNF233 variant is less likely to cause harmful effects and can be considered a potential drug target or biomarker.

The ZNF233 variant has also been shown to have unique genetic interactions with other genes. For example, studies have shown that the ZNF233 variant is located on the same gene cluster as the gene encoding the transcription factor PLCG1, which is involved in the regulation of cell growth and differentiation. This suggests that the ZNF233 variant may interact with PLCG1 and affect its function.

Finally, the ZNF233 variant has also been shown to have unique functional interactions with other proteins and factors. For example, studies have shown that the ZNF233 variant is involved in the regulation of the expression of the gene encoding the protein FBN1, which is involved in the formation of blood vessels. This suggests that the ZNF233 variant may be involved in the regulation of FBN1 function and have implications for the development and maintenance of blood vessels.

In conclusion, ZNF233 (ZNF233 variant 1) is a unique gene that encodes for a protein with distinct functional characteristics compared to the other splice variants. Its stability, lack of expression in many tissues, genetic interactions with other genes and proteins, and functional interactions with other proteins and factors make it a potential drug target or biomarker. Further research is needed to fully understand the role of ZNF233 in the development and maintenance of tissues and to explore its potential as a therapeutic target.

Protein Name: Zinc Finger Protein 233

Functions: May be involved in transcriptional regulation

The "ZNF233 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF233 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382